Publicaciones en colaboración con investigadores/as de Novo Nordisk (1)

2024

  1. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

    The Lancet Neurology, Vol. 23, Núm. 3, pp. 243-255